Researcher profile

Anna Zajakina, Anna Strelnikova

Dr. Anna Zajakina is the head of Cancer Gene Therapy group at Latvian Biomedical Research and Study Centre. She has completed her PhD in 2005 at University of Latvia, Molecular Biology, Virology and Biochemistry Division. She raised her expertise at University of Rostock (Germany), Uppsala University (Sweden) and University of Bordeaux (France). Dr. Zajakina (Strelnikova) is the author of 23 papers and more then 30 conference presentations related to cancer research, vaccinology, molecular biology and virology issues. Since 2012, the main research interests include the development of novel clinically translatable gene therapy methods for treatment of infectious diseases and cancer. Dr. Zajakina supervises and/or participates in collaborative research projects focused on delivery of therapeutic genes by viral vectors into tumors for smart regulation of tumor microenvironment in combination of polyfunctional drugs. Being a national coordinator of European Biotechnology Thematic Network Association, Dr. Zajakina is actively taking part in organization and hosting of international workshops, seminars and conferences, working in cooperation with students and researchers representing various organizations.